Cat.#: ACPP-1839
| Despition | Ornithine Aminotransferase Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1219 | Prominin 1 Blocking Peptide (AC1219) | 250 µg | inquiry |
| ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
| ACPP-1327 | Dopamine Receptor D1 Blocking Peptide (AC1327) | 250 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1078 | Glutamate Receptor 1 Blocking Peptide (AC1078) | 250 µg | inquiry |
| ACPP-1173 | Recombinant Human alpha Synuclein Protein (AC1173) | 50 µl | inquiry |
| ACPP-1621 | Human LZIC Protein (AC1621) | 5 µg | inquiry |
| ACPP-1668 | Human BDNF Protein, His (AC1668) | 5 µg | inquiry |
| ACPP-1306 | FGFR2 Blocking Peptide (AC1306) | 250 µg | inquiry |
| ACPP-1531 | Human CHMP2B Protein (AC1531) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.